Delivery Order SPE2DB20D1100-SPE2DB25FD5G7
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $37K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,106.33 to AmerisourceBergen Drug Corp for 60-count tablets of Xifaxan 550 mg, an antibiotic used to treat traveler's diarrhea and certain gastrointestinal conditions. This firm fixed price contract, awarded on August 18, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,991.41 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on August 20, 2025, with completion scheduled for August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $90,183.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Xifaxan 550 mg, an antibiotic medication commonly used to treat traveler's diarrhea and hepatic encephalopathy. This competitively awarded, non-set-aside delivery order has an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,344.55 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on June 4, 2025, with a completion date of June 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.9...
- The Defense Logistics Agency awarded a delivery order valued at $7,595.77 to AmerisourceBergen Drug Corp for 60-count tablets of Xifaxan 550 mg, an antibiotic medication commonly used to treat traveler's diarrhea and hepatic encephalopathy. The contract was competitively awarded without set-aside restrictions on August 15, 2025, with an ultimate completion date of August 18, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $61,645.25 to AmerisourceBergen Drug Corp for 60-count bottles of Xifaxan 550 mg tablets, with a firm fixed price and ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that enables the...
- The Defense Logistics Agency awarded a $35,933.54 delivery order to AmerisourceBergen Drug Corp for Xifaxan 550 mg tablets (60-count packages) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $24,690.56 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for delivery to the Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xifaxan 550 mg tablets (60-count units) on June 26, 2025, with a ceiling value of $20,364.81 and a firm fixed price structure. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999 and extends through December 2026. The place of performance is located...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,985.98 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units). This non-set-aside, competitively awarded contract utilizes firm fixed price terms with an ultimate completion date of August 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its Pennsylvania facility. This delivery order...